Pfizer and the Friends of Haemophilia Society have launched an app game specifically designed to help boys aged four years and older learn about and manage their hemophilia.
Released in Qatar, “HemoHeroes” tasks players with guiding their ‘hero’ through different everyday scenarios, such as exercising, cooking, and bathing. While each of these are designed to be a fun challenge, they also focus...
Two years after launching its smoking cessation app Quitter's Circle, pharmaceutical company Pfizer is seeing impressive continued engagement with the app. It's also applying the lessons learned from Quitter's Circle toward other mobile health pursuits — including a recently-launched app for people living with cancer.
"We can do surveys right in the app," Mark Pizzini, Pfizer's digital strategy...
Boston-based Akili Interactive Labs and Pfizer have released data from a collaborative study showing the use of Akili’s digital, cognitive measurement platform can detect biomarkers of Alzheimer’s disease.
The study, which began in 2014, used Akili’s screening technology called AD Screen. The program targets the brain's interference processing system and then uses an algorithm to deploy a...
Global pharmaceutical company Pfizer has launched a new consumer-facing app aimed at helping to motivate adults with depression. The app, called Moodivator, will be available for free on the iOS app store.
“As awareness of the magnitude and severity of depression continues to mount, technology like the Moodivator app represents a new and exciting frontier for helping people with depression," Dr...
Digital medicine company Akili Interactive Labs announced an $11.9 million expansion of its recent Series B funding, adding new investors into the round and bringing the series total to $42.4 million.
The Dutch subsidiary of Merck Ventures, known as M Ventures in the US and Canada, and the venture arm of Amgen joined existing investors, which include Pfizer and Shire Pharmaceuticals. This means...
Correction: A previous version of this article contained inaccuracies based on an out-of-date version of the research proposal.
Pfizer is working with Brigham and Women's Hospital in Boston to test an app for rheumatoid arthritis in a small clinical trial, according to a ClinicalTrials.gov posting. One hundred and ninety patients will be enrolled in the trial, which is set to conclude in...
More and more, pharma companies are making real bets in digital health, and reorganizing their businesses to put some power behind those efforts. The space is, in some ways, quieter than it was this time last year, but there’s reason to believe that quiet is a calm before a storm of activity, driven more by pharma’s tendency to keep early-stage projects close to the chest than by a lack of...
Pfizer has partnered with IBM to develop a system that clinicians can use to treat patients who have Parkinson’s disease. The system will make use of sensors, mobile devices, and machine learning to provide clinicians and researchers with symptom information, which they will then use to better understand patient disease progression and medication response. It will also help inform treatment...
Pfizer Consumer Healthcare, a division of Pfizer that maintains consumer health brands including Advil, Caltrate, Centrum, ChapStick, and Nexium24 HR, has partnered with education company Galvanize to launch a health tech accelerator.
The six month program will launch in early March at Galvanize’s San Francisco office. Pfizer and Galvanize plan to accept ten companies focused on improving sleep,...
NYC-based pharma company Pfizer currently has 15 apps in the US iOS app store, ranging from a chapstick companion app to an app for people with kidney cancer. At the HIMSS Connected Health Summit in National Harbor, Maryland, Pfizer executives talked about two of the company's apps and their broader strategy for developing mobile health interventions.
"We recognize that the data shows patients...
.jpeg?itok=HF3iI7dj "Person answering their front door and getting a delivery from another person")
